Skip to content
2000
Volume 22, Issue 3
  • ISSN: 1567-2026
  • E-ISSN: 1875-5739

Abstract

Introduction

Although ischemic stroke is associated with complex changes in the autonomic nervous system, the circadian patterns of heart rate (HR) and heart rate variability (HRV) in wake-up stroke (WUS) remain poorly understood. This study compared 24-hour heart rate and HRV patterns between patients with and without WUS.

Methods

This retrospective observational case-control study involved 104 patients with acute ischemic stroke (9 WUS, 95 non-WUS). HRV analysis was performed using a 14-day continuous electrocardiography patch monitor. Time- and frequency-domain HRV metrics were calculated, and 24-hour differences were assessed using generalized additive mixed models (GAMMs), adjusting for confounders.

Results

WUS patients had significantly higher HRs (80.60 ± 12.49 . 73.22 ± 14.49 beats per minute, < 0.001) and lower HRV-measured by SDNN (28.06 ± 21.68 . 39.70 ± 25.73 milliseconds, < 0.001), RMSSD (15.78 ± 12.49 . 22.16 ± 19.22 milliseconds, < 0.001), and pNN50 (1.03% ± 2.78% . 2.61% ± 5.15%, < 0.001)-than non-WUS patients. GAMMs indicated that patients with WUS experienced significant autonomic dysregulation, characterized by higher HRs, lower HRV, and altered circadian rhythms compared to those with non-WUS. These differences were particularly evident during the early morning hours.

Discussion

WUS patients exhibited distinct 24-hour HR and HRV profiles, characterized by higher HRs and reduced autonomic variability compared to non-WUS patients. These differences align with patterns typically associated with lower parasympathetic activity rather than elevated sympathetic tone.

Conclusion

WUS is associated with impaired autonomic regulation and disrupted circadian patterns of HR and HRV.

Loading

Article metrics loading...

/content/journals/cnr/10.2174/0115672026418606251007070743
2025-10-21
2026-03-06
Loading full text...

Full text loading...

References

  1. AlladaR. BassJ. Circadian mechanisms in medicine.N. Engl. J. Med.2021384655056110.1056/NEJMra1802337 33567194
    [Google Scholar]
  2. BaschieriF. CortelliP. Circadian rhythms of cardiovascular autonomic function: Physiology and clinical implications in neurodegenerative diseases.Auton. Neurosci.20192179110110.1016/j.autneu.2019.01.009 30744907
    [Google Scholar]
  3. SammitoS. ThielmannB. BöckelmannI. Update: Factors influencing heart rate variability–a narrative review.Front. Physiol.202415143045810.3389/fphys.2024.1430458 39165281
    [Google Scholar]
  4. HayterE.A. WehrensS.M.T. Van DongenH.P.A. Distinct circadian mechanisms govern cardiac rhythms and susceptibility to arrhythmia.Nat. Commun.2021121247210.1038/s41467‑021‑22788‑8 33931651
    [Google Scholar]
  5. ShafferF. GinsbergJ.P. An overview of heart rate variability metrics and norms.Front. Public Health2017525810.3389/fpubh.2017.00258 29034226
    [Google Scholar]
  6. SinghB. HuangD. The role of circadian rhythms in stroke: A narrative review.Neurochem. Res.202449229030510.1007/s11064‑023‑04040‑5 37838637
    [Google Scholar]
  7. ZhangL. WuH. ZhangX. WeiX. HouF. MaY. Sleep heart rate variability assists the automatic prediction of long-term cardiovascular outcomes.Sleep Med.20206721722410.1016/j.sleep.2019.11.1259 31972509
    [Google Scholar]
  8. KamatP.K. KhanM.B. SmithC. The time dimension to stroke: Circadian effects on stroke outcomes and mechanisms.Neurochem. Int.202316210545710.1016/j.neuint.2022.105457 36442686
    [Google Scholar]
  9. LoE.H. FaraciF.M. Circadian mechanisms in cardiovascular and cerebrovascular disease.Circ. Res.2024134661561710.1161/CIRCRESAHA.124.324462 38484030
    [Google Scholar]
  10. ZhangW. LiQ. ZouN. ZhangG. QinX. ZhuC. Clinical characteristics and functional outcomes of wake-up stroke in the Chinese population.Eur. Neurol.202083213814610.1159/000506198 32492689
    [Google Scholar]
  11. SilvaG.S. LimaF.O. CamargoE.C.S. Wake-up stroke: Clinical and neuroimaging characteristics.Cerebrovasc. Dis.201029433634210.1159/000278929 20130399
    [Google Scholar]
  12. ZhangY.L. ZhangJ.F. WangX.X. WangY. AndersonC.S. WuY.C. Wake-up stroke: Imaging-based diagnosis and recanalization therapy.J. Neurol.2021268114002401210.1007/s00415‑020‑10055‑7 32671526
    [Google Scholar]
  13. Jiménez-CondeJ. OisA. Rodríguez-CampelloA. GomisM. RoquerJ. Does sleep protect against ischemic stroke? Less frequent ischemic strokes but more severe ones.J. Neurol.2007254678278810.1007/s00415‑006‑0438‑y 17351725
    [Google Scholar]
  14. Menéndez AlbarracínA. Valls CarbóA. Rabaneda LombarteN. Time of the day and season distribution among stroke code subtypes: Differences between ischemic stroke, intracranial hemorrhage, and stroke mimic.Front. Neurol.202415137232410.3389/fneur.2024.1372324 38595853
    [Google Scholar]
  15. FodorD.M. MartaM.M. Perju-DumbravăL. Implications of circadian rhythm in stroke occurrence: Certainties and possibilities.Brain Sci.202111786510.3390/brainsci11070865 34209758
    [Google Scholar]
  16. DimovaV. Welte-JzykC. KronfeldA. Brain connectivity networks underlying resting heart rate variability in acute ischemic stroke.Neuroimage Clin.20244110355810.1016/j.nicl.2023.103558 38142520
    [Google Scholar]
  17. ElectrophysiologyT.F.E.S.C.N.A. Heart rate variability: Standards of measurement, physiological interpretation and clinical use.Circulation19969351043106510.1161/01.CIR.93.5.1043 8598068
    [Google Scholar]
  18. ElliottW.J. Circadian variation in the timing of stroke onset: a meta-analysis.Stroke199829599299610.1161/01.STR.29.5.992 9596248
    [Google Scholar]
  19. LundholmM.D. RooneyM. MaasM.B. AttarianH. PrabhakaranS. Wake-up stroke is associated with greater nocturnal mean arterial pressure variability.Stroke20174861668167010.1161/STROKEAHA.116.016202 28455315
    [Google Scholar]
  20. MaY. ChangM.C. LitrownikD. WayneP.M. YehG.Y. Day-night patterns in heart rate variability and complexity: Differences with age and cardiopulmonary disease.J. Clin. Sleep Med.202319587388210.5664/jcsm.10434 36692177
    [Google Scholar]
  21. YoungM.E. The cardiac circadian clock.JACC Basic Transl. Sci.20238121613162810.1016/j.jacbts.2023.03.024 38205356
    [Google Scholar]
  22. RennaN.F. RamirezJ.M. MuruaM. Morning blood pressure surge as a predictor of cardiovascular events in patients with hypertension.Blood Press. Monit.202328314915710.1097/MBP.0000000000000641 37058087
    [Google Scholar]
  23. BiloG. GrilloA. GuidaV. ParatiG. Morning blood pressure surge: Pathophysiology, clinical relevance and therapeutic aspects.Integr. Blood Press. Control201811475610.2147/IBPC.S130277 29872338
    [Google Scholar]
  24. MaqsoodM.H. MesserliF.H. SkolnickA.H. NewmanJ.D. BergerJ.S. BangaloreS. Timing of antihypertensive drug therapy: A systematic review and meta-analysis of randomized clinical trials.Hypertension20238071544155410.1161/HYPERTENSIONAHA.122.20862 37212152
    [Google Scholar]
  25. WuC. ZhaoP. XuP. Evening versus morning dosing regimen drug therapy for hypertension.Cochrane Libr.202420242CD00418410.1002/14651858.CD004184.pub3 38353289
    [Google Scholar]
  26. MackenzieI.S. RogersA. PoulterN.R. Cardiovascular outcomes in adults with hypertension with evening versus morning dosing of usual antihypertensives in the UK (TIME study): A prospective, randomised, open-label, blinded-endpoint clinical trial.Lancet2022400103611417142510.1016/S0140‑6736(22)01786‑X 36240838
    [Google Scholar]
  27. HsiaoS.H. HwangT.J. LinF.J. SheuJ.J. WuC.H. The association between the use of cholinesterase inhibitors and cardiovascular events among older patients with alzheimer disease.Mayo Clin. Proc.202196235036210.1016/j.mayocp.2020.05.048 33549256
    [Google Scholar]
  28. ShahimB. XuH. HaugaaK. Cholinesterase inhibitors are associated with reduced mortality in patients with Alzheimer’s disease and previous myocardial infarction.Eur. Heart J. Cardiovasc. Pharmacother.202410212813610.1093/ehjcvp/pvad102 38224338
    [Google Scholar]
  29. HsiehM.J. ChenD.Y. LeeC.H. Association between cholinesterase inhibitors and new-onset heart failure in patients with Alzheimer’s disease: A nationwide propensity score matching study.Front. Cardiovasc. Med.2022983173010.3389/fcvm.2022.831730 35369359
    [Google Scholar]
  30. BehlingA. MoraesR.S. RohdeL.E. FerlinE.L. NóbregaA.C.L. RibeiroJ.P. Cholinergic stimulation with pyridostigmine reduces ventricular arrhythmia and enhances heart rate variability in heart failure.Am. Heart J.2003146349450010.1016/S0002‑8703(03)00319‑3 12947369
    [Google Scholar]
  31. NóbregaA.C.L. dos ReisA.F. MoraesR.S. BastosB.G. FerlinE.L. RibeiroJ.P. Enhancement of heart rate variability by cholinergic stimulation with pyridostigmine in healthy subjects.Clin. Auton. Res.2001111111710.1007/BF02317797 11503945
    [Google Scholar]
  32. MartoranaA. EspositoZ. KochG. Beyond the cholinergic hypothesis: Do current drugs work in Alzheimer’s disease?CNS Neurosci. Ther.201016423524510.1111/j.1755‑5949.2010.00175.x 20560995
    [Google Scholar]
/content/journals/cnr/10.2174/0115672026418606251007070743
Loading
/content/journals/cnr/10.2174/0115672026418606251007070743
Loading

Data & Media loading...

Supplements

Supplementary material is available on the publisher’s website along with the published article.

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test